SCHEMBL4671276

SCHEMBL4671276

O=C1c2ccc(Cl)cc2C(=O)N1c1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.55
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 3/20 0.54
GAA P10253 1/20 0.54
MEN1 O00255 7/20 0.53
KMT2A Q03164 7/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
MAPT P10636 4/20 0.51
PDCD1 Q15116 1/20 0.51
CD274 Q9NZQ7 1/20 0.51
POLB P06746 3/20 0.48
LMNA P02545 2/20 0.48
MITF O75030 1/20 0.48
CASP6 P55212 1/20 0.48
HPGD P15428 2/20 0.47
S1PR4 O95977 1/20 0.46
XBP1 P17861 1/20 0.46
S1PR1 P21453 1/20 0.46
CCR6 P51684 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10529078 0.83 POLB (0.60) NPC1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL18589087 0.83 ALDH1A1 (0.57) NPC1ALDH1A1KDM4EGAAMEN1
SCHEMBL30817653 0.82 ALDH1A1 (0.73) NPC1ALDH1A1KDM4EGAAMEN1
SCHEMBL7479419 0.82 ALDH1A1 (0.73) NPC1ALDH1A1KDM4EGAAMEN1
SCHEMBL30817652 0.82 ALDH1A1 (0.73) NPC1ALDH1A1KDM4EGAAMEN1
SCHEMBL15046562 0.81 SMN1; SMN2 (0.62) NPC1ALDH1A1KDM4EGAAMEN1
SCHEMBL14357435 0.79 KDM4E (0.74) NPC1ALDH1A1KDM4EGAAMEN1
SCHEMBL17946639 0.78 KMT2A (0.64) NPC1ALDH1A1KDM4EGAAMEN1
SCHEMBL14095272 0.78 ALDH1A1 (0.51) NPC1ALDH1A1KDM4EGAAMEN1
SCHEMBL3976791 0.78 MEN1 (0.53) NPC1ALDH1A1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1403303-B1 Methods for the preparation of poly(etherimide)s GEN ELECTRIC (US) 2008-08-20 EP disclosed
CN-1294180-C Preparation method of poly (diimide ether) GEN ELECTRIC (US) 2007-01-10 CN disclosed
US-6881815-B2 Method for the preparation poly(etherimide)s GENERAL ELECTRIC COMPANY (US) 2005-04-19 US disclosed
CN-1497006-A Preparation method of poly (diimide ether) 通用电气公司 2004-05-19 CN disclosed
US-20040063897-A1 Method for the preparation poly(etherimide)s SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2004-04-01 US disclosed
EP-1403303-A1 Methods for the preparation of poly(etherimide)s General Electric Company (US) 2004-03-31 EP disclosed
US-5194566-A Polyarylene sulfide block copolymers, method for making, and use GENERAL ELECTRIC COMPANY (US) 1993-03-16 US disclosed
EP-0293692-A2 Polyarylene sulfide block copolymers, method for making, and use GENERAL ELECTRIC COMPANY (US) 1988-12-07 EP disclosed
US-4769424-A Polyarylene sulfide block copolymers, method for making, and use GENERAL ELECTRIC COMPANY (US) 1988-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063897-A1 Method for the preparation poly(etherimide)s FHIT, PBRM1, PMAIP1 NPC1 4848/4885ALDH1A1 1691/4885KDM4E 414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.